Sebastiani G - Search Results

1

Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.

Sagrini E, Ardoino I, Marano G, Gianstefani A, Orlandini A, Sebastiani G, Donati G, Cucchetti A, Pelosi G, Ferrari C, Alberti A, Biganzoli E, Piscaglia F, Bolondi L. Sagrini E, et al. Among authors: sebastiani g. Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1385-95. doi: 10.1097/MEG.0b013e328363e29d. Eur J Gastroenterol Hepatol. 2013. PMID: 23839163

2

Natural history of initially mild chronic hepatitis C.

Alberti A, Benvegnù L, Boccato S, Ferrari A, Sebastiani G. Alberti A, et al. Among authors: sebastiani g. Dig Liver Dis. 2004 Oct;36(10):646-54. doi: 10.1016/j.dld.2004.06.011. Dig Liver Dis. 2004. PMID: 15506661 Review.

3

Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection: response to Lecube et al.

Sebastiani G, Vario A, Alberti A. Sebastiani G, et al. Diabetes Care. 2005 Jul;28(7):1838; author reply 1838-9. doi: 10.2337/diacare.28.7.1838. Diabetes Care. 2005. PMID: 15983357 No abstract available.

4

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse.

Gerotto M, Dal Pero F, Bortoletto G, Ferrari A, Pistis R, Sebastiani G, Fagiuoli S, Realdon S, Alberti A. Gerotto M, et al. Among authors: sebastiani g. J Hepatol. 2006 Jan;44(1):83-7. doi: 10.1016/j.jhep.2005.08.016. Epub 2005 Sep 21. J Hepatol. 2006. PMID: 16271794

5

Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.

Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A. Sebastiani G, et al. J Viral Hepat. 2006 Mar;13(3):199-205. doi: 10.1111/j.1365-2893.2005.00662.x. J Viral Hepat. 2006. PMID: 16475996

6

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Sebastiani G, et al. J Hepatol. 2006 Apr;44(4):686-93. doi: 10.1016/j.jhep.2006.01.007. Epub 2006 Feb 8. J Hepatol. 2006. PMID: 16490278

7

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Sebastiani G, Alberti A. Sebastiani G, et al. World J Gastroenterol. 2006 Jun 21;12(23):3682-94. doi: 10.3748/wjg.v12.i23.3682. World J Gastroenterol. 2006. PMID: 16773685 Free PMC article. Review.

8

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.

Sebastiani G, Vario A, Guido M, Alberti A. Sebastiani G, et al. World J Gastroenterol. 2007 Jan 28;13(4):525-31. doi: 10.3748/wjg.v13.i4.525. World J Gastroenterol. 2007. PMID: 17278217 Free PMC article.

9

Clinical trial: comparison of weekly once versus twice half-dose weekly administration of pegylated interferon alpha 2b in combination with ribavirin for the treatment of HCV-1 positive patients with chronic hepatitis C.

Sebastiani G, Ferrari A, Boccato S, Pistis R, Alberti A. Sebastiani G, et al. Aliment Pharmacol Ther. 2007 Oct 1;26(7):1077-82. doi: 10.1111/j.1365-2036.2007.03451.x. Aliment Pharmacol Ther. 2007. PMID: 17877515 Free article. Clinical Trial.

10

Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.

Sebastiani G, Vario A, Guido M, Alberti A. Sebastiani G, et al. J Viral Hepat. 2008 Mar;15(3):212-8. doi: 10.1111/j.1365-2893.2007.00932.x. Epub 2007 Dec 28. J Viral Hepat. 2008. PMID: 18179453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

523 results

Search Page